Uterine Transplantation in Transgender Women: Medical, Legal and Ethical Considerations by Hammond-Browning, Natasha
This is a peer­reviewed, post­print (final draft post­refereeing) version of the following published document, 
This is the pre­peer reviewed version of the following article: Uterine Transplantation in Transgender 
Women: Medical, Legal and Ethical Considerations, which has been published in final form at 
https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/1471­ 0528.15482 and is licensed under All Rights 
Reserved license:
Hammond­Browning, Natasha ORCID: 0000­0002­2371­2479 (2019) Uterine 
Transplantation in Transgender Women: Medical, Legal and Ethical 
Considerations. BJOG: An International Journal of Obstetrics and 
Gynaecology, 126 (2). p. 157. ISSN 1470­0328 
Official URL: https://doi.org/10.1111/1471­0528.15482
DOI: http://dx.doi.org/10.1111/1471­0528.15482
EPrint URI: http://eprints.glos.ac.uk/id/eprint/6040
Disclaimer 
The University of Gloucestershire has obtained warranties from all depositors as to their title in the material 
deposited and as to their right to deposit such material.  
The University of Gloucestershire makes no representation or warranties of commercial utility, title, or fitness 
for a particular purpose or any other warranty, express or implied in respect of any material deposited.  
The University of Gloucestershire makes no representation that the use of the materials will not infringe any 
patent, copyright, trademark or other property or proprietary rights.  
The University of Gloucestershire accepts no liability for any infringement of intellectual property rights in any 
material deposited but will remove such material from public view pending investigation in the event of an 
allegation of any such infringement. 
PLEASE SCROLL DOWN FOR TEXT.
This	 is	 the	 pre-peer	 reviewed	 version	 of	 the	 following	 article:	 Uterine	
Transplantation	 in	 Transgender	 Women:	 Medical,	 Legal	 and	 Ethical	
Considerations,	 which	 has	 been	 published	 in	 final	 form	 at	
https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/1471-
0528.15482		
	
Mini	Commentary	on	2018-CM-22012R1:	Uterine	
Transplantation	in	Transgender	Women:	Medical,	Legal	and	
Ethical	Considerations	
	
Dr	N	Hammond-Browning	
Senior	Lecturer	in	Law	
University	of	Gloucestershire	
Oxstalls	Campus	
Oxstalls	Lane	
Longlevens	
Gloucester	
Gloucestershire	
GL2	9HW			Uterine	transplantation	(UTx)	is	the	only	reproductive	technology	that	provides	a	 reproductive	 solution	 for	women	with	 absolute	 uterine	 factor	 infertility	 that	allows	them	to	gestate.	Since	the	announcement	of	 the	first	 live	birth	following	UTx	 there	has	been	 considerable	 interest	 from	 the	 trans	 community	 regarding	the	possibility	of	uterine	transplantation	for	transgender	women.	UTx	offers	the	potential	 to	 realign	 reproductive	 capacity	 and	widen	 the	 reproductive	 options	for	transgender	women	(Alghrani,	JLB;	2018).	Whilst	not	yet	medically	feasible,	it	 is	 important	to	consider	the	medical	barriers	alongside	the	ethical,	 legal,	and	social	 issues	 that	UTx	 in	 transgender	women	 raise.	 Currently,	 this	 is	 an	 under	discussed	area,	and	as	such	Jones	et	al	provide	an	important	contribution	to	the	literature	(Jones	et	al,	BJOG;	2018:XXX).	Jones	et	al	note	that	UTx	in	transgender	women	may	be	ethically	and	legally	permissible	due	to	considerations	of	justice,	equality,	and	non-discrimination.	However,	the	importance	of	the	paper	is	with	regards	 to	 the	 education,	 elucidation,	 and	discussion	of	 the	medical	 difficulties	requiring	further	investigation	prior	to	any	attempts.		What	 is	apparent	 is	 that	 the	medical	barriers	are	not	 insurmountable.	A	utero-vaginal	transplant	is	suggested	owing	to	the	need	to	utilise	as	much	donor	vagina	as	possible,	with	it	further	recommended	that	retrieval	be	from	deceased	donors	due	 to	 the	 more	 radical	 hysterectomy.	 Controversially,	 female	 to	 male	transgender	 men	 are	 also	 suggested	 as	 possible	 donors.	 There	 is	 a	 need	 to	balance	the	interests	of	living	donors	and	recipients:	living	donors	should	not	be	exposed	 to	 unnecessary	 risks	 in	 order	 to	 increase	 benefits	 to	 recipients.	 This	suggestion	 requires	 further	 legal,	 ethical,	 and	 medical	 evaluation.	 The	 trans-community	 need	 information	 about	 the	 possibility	 of	 UTx,	 and	 Jones	 et	 al	demonstrate	 the	 need	 for	 further	 research	 before	 any	 attempts	 at	 UTx	 in	transgender	women.		
	Whilst	 ethical	 and	 legal	 considerations	 have	 been	 alluded	 to,	 contemplation	 of	these	 issues	 is	 vital	 before	 further	 medical	 advances,	 particularly	 as	 UTx	 in	transgender	 women	 also	 raises	 the	 possibility	 of	 male	 pregnancy.	 It	 is	undeniable	that	transgender	people	must	not	be	discriminated	against,	however,	currently	in	the	UK,	it	appears	that	embryo	transfer	into	a	person	who	was	not	born	a	woman	is	illegal	(s3(2)(a)	and	s3ZA	(6)(a)	HFE	Act	1990	(as	amended)).	Therefore,	 even	 if	 medically	 feasible	 to	 perform	 UTx	 on	 transgender	 women,	they	would	not	be	able	to	undergo	embryo	transfer,	and	subsequent	pregnancy.			Ethical	 debate	 and	 deliberation	 must	 also	 be	 given	 to	 justice,	 equality,	 and	procreative	 liberty	 (amongst	 others).	 Robertson	 (JLB;	 2017:4(3)	 630-636)	 and	Alghrani	(JLB;	2016:3(3)	636-641	and	JLB;	2018)	have	started	the	debate	on	the	right	to	gestate	in	light	of	UTx,	and	the	establishment	of	this	right	will	be	vital	to	support	transgender	women	accessing	UTx.			The	medical	problems	discussed	by	 Jones	et	al.	must	be	debated	alongside	 the	ethics	and	 legality	of	providing	UTx	 to	 transgender	women.	 In	order	 to	ensure	that	 any	 future	 legislation	 is	 fit	 for	 purpose,	 it	 is	 imperative	 that	 there	 is	proactive	debate	of	 the	ethics	of	UTx	 in	order	 to	avoid	reactive	 legislation	 that	may	 be	 implemented	 once	 UTx	 is	 proven	 as	 a	 medically	 safe	 and	 effective	treatment.	 Only	 through	 proactive	 debate,	 encompassing	 all	 aspects,	 can	reasoned	decisions	on	UTx	for	transgender	women	be	made.		
